Verrica Pharmaceuticals buy Needham & Company LLC
Start price
15.08.24
/
50%
€2.62
Target price
15.08.25
€10.95
Performance (%)
-39.00%
Price
17.09.24
€1.63
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL for Verrica Pharmaceuticals is performing very badly with a performance of -39.00%. This prediction currently runs until 15.08.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Verrica Pharmaceuticals | -3.916% | -3.916% |
iShares Core DAX® | 1.887% | 1.967% |
iShares Nasdaq 100 | 2.316% | -1.227% |
iShares Nikkei 225® | 1.134% | 0.390% |
iShares S&P 500 | 1.821% | 0.790% |
Comments by Needham___Company_LL for this prediction
In the thread Discuss Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its price target lowered by analysts at Needham & Company LLC from $16.00 to $12.00. They now have a "buy" rating on the stock.
Ratings data for VRCA provided by MarketBeat
Stopped prediction by Needham___Company_LL for Verrica Pharmaceuticals
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€9.90
14.05.24
14.05.24
€14.81
14.05.25
14.05.25
-83.87%
17.09.24
17.09.24
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€2.74
10.11.23
10.11.23
€7.49
10.11.24
10.11.24
-37.08%
17.09.24
17.09.24
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€3.90
23.08.23
23.08.23
€9.25
23.08.24
23.08.24
-38.46%
24.08.24
24.08.24